Filip Miljković
University of Bonn(DE)AstraZeneca (Australia)(AU)AstraZeneca (Netherlands)(NL)AstraZeneca (Sweden)(SE)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Protein Structure and Dynamics, Microbial Natural Products and Biosynthesis, Machine Learning in Materials Science, Metabolomics and Mass Spectrometry Studies
Most-Cited Works
- → Interpretable bilinear attention network with domain adaptation improves drug–target prediction(2023)291 cited
- → Machine Learning Models for Human In Vivo Pharmacokinetic Parameters with In-House Validation(2021)89 cited
- → Prediction of In Vivo Pharmacokinetic Parameters and Time–Exposure Curves in Rats Using Machine Learning from the Chemical Structure(2022)74 cited
- → QSAR models for HEPT derivates as NNRTI inhibitors based on Monte Carlo method(2014)69 cited
- → Structure- and Similarity-Based Survey of Allosteric Kinase Inhibitors, Activators, and Closely Related Compounds(2021)66 cited
- → Machine Learning Models for Accurate Prediction of Kinase Inhibitors with Different Binding Modes(2019)58 cited